Preventing Hepatitis B Reactivation During Anti‐CD20 Antibody Treatment in the Veterans Health Administration

Hepatitis B virus (HBV) reactivation may occur with high risk immunosuppression, such as anti‐cluster of differentiation (CD)20 antibodies (Abs). Appropriate HBV prophylaxis during anti‐CD20 Ab therapy averts hepatitis, chemotherapy disruption, and death. Serologic evidence of prior HBV exposure is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatol Commun
Main Authors: Jasmine Bullard, A., Cunningham, Francesca E., Volpp, Bryan D., Lowy, Elliott, Beste, Lauren A., Heron, Bernadette B., Geraci, Mark, Hammond, Julia M., LaPlant, Kourtney, Stave, Elise A., Turner, Marsha J., O’Leary, Meghan C., Kelley, Michael J., Hunt, Christine M.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6128236/
https://ncbi.nlm.nih.gov/pubmed/30202826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1238
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados